Search
Serina Therapeutics Inc
SERAdd to Watchlist
2.190USD
-0.120-5.19%
Close 09-23 16:00（ET）
32.85MMarket Cap
LossP/E TTM
After-hours 18:30 (ET)2.190USD-0.060-2.67%
After-hours 18:30 (ET)Serina Therapeutics Inc (SER) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Serina Therapeutics Inc in the past month.
Strong Buy
1 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
9.500USD+311.26%
SER Analyst Recommendation Trends
In the current month, SER has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SER average Analyst price target in the last month is 9.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
0
0
0
0
0
0
1
1
1
1
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
1
1
2
2
2
2
SER Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, SER EPS is projected to reach -0.340 in FY2026Q3, following reported EPS of -0.545 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.46
-0.44
-0.47
-0.34
-0.30
Actual
-0.31
-0.58
-0.55
--
--
Surprise
+31.99%
-30.83%
-17.23%
--
--
FAQs
What is Serina Therapeutics Inc's price target?
Analysts forecast that Serina Therapeutics Inc's price target is USD 9.50, with the highest forecast at USD 11.00 and the lowest forecast at USD 8.00.
How have Serina Therapeutics IncSER's recent earnings per share performed?
The market expectation was USD -0.55, while Serina Therapeutics IncSER's earnings per share (EPS) for the previous quarter was USD -0.58. EPS for the next quarter is expected at USD -0.34.
What is the analyst rating for Serina Therapeutics Inc?
Based on the ratings of Serina Therapeutics Inc's stock from 2 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.